Edesa Biotech Extends COVID-19 Clinical Study to Poland
Go back to Edesa Biotech Extends COVID-19 Clinical Study to Poland| (NASDAQ: EDSA) | Delayed: 2.70 +0.05 (1.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.65 | 52 Week High | $ | |||
| Open | $2.62 | 52 Week Low | $ | |||
| Day High | $2.79 | P/E | N/A | |||
| Day Low | $2.54 | EPS | $ | |||
| Volume | 64,289 | |||||



